-
Product Insights
Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include a lump that can be felt through the skin on the neck, difficulty swallowing, pain in neck and throat, and swollen lymph nodes in the neck. Predisposing factors include female sex, high levels of radiation exposure, and inherited genetic syndromes. Treatment includes surgery and thyroid hormone therapy. The Thyroid...
-
Product Insights
Neuroblastoma - Drugs In Development, 2024
Empower your strategies with our Neuroblastoma – Drugs In Development, 2024 report and make more profitable business decisions. Neuroblastoma is the cancer of the nerve tissues and neural crest cells of adrenal glands, neck, chest, or spinal cord, occurring predominantly in children. It usually begins in the adrenal glands before spreading to other parts of the body. The predisposing factors involved in neuroblastoma include genetic conditions. Symptoms include a lump in the abdomen or chest, weakness, bone pain, breathing problems, dark...
-
Product Insights
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) - Drugs In Development, 2024
Empower your strategies with our B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) – Drugs In Development, 2024 report and make more profitable business decisions. B-cell acute lymphocytic leukemia (B-Cell ALL), also known as B-cell acute lymphoblastic leukemia, is a type of blood cancer that originates in the bone marrow and affects B-cell lymphocytes, a type of white blood cell. In B-cell ALL, these immature B cells undergo malignant transformation, leading to the rapid production of abnormal lymphoblasts. These abnormal cells...
-
Product Insights
Gastroesophageal (GE) Junction Carcinomas - Drugs In Development, 2024
Empower your strategies with our Gastroesophageal (GE) Junction Carcinomas – Drugs In Development, 2024 report and make more profitable business decisions. Gastroesophageal (GE) junction carcinomas are malignancies occurring at the point where the esophagus meets the stomach. Typically classified as adenocarcinomas or squamous cell carcinomas, adenocarcinomas are more prevalent. Risk factors include chronic gastroesophageal reflux disease (GERD), obesity, and smoking. Symptoms often manifest in advanced stages, including difficulty swallowing, weight loss, and abdominal pain. Diagnosis involves endoscopic procedures and imaging studies....
-
Product Insights
Neuroendocrine Cancer - Drugs In Development, 2024
Empower your strategies with our Neuroendocrine Cancer – Drugs In Development, 2024 report and make more profitable business decisions. A neuroendocrine cancer, often referred as a neuroendocrine tumor (NET) or neuroendocrine neoplasm, begins in the specialized cells of the body’s neuroendocrine system. These cells have traits of both hormone-producing endocrine cells and nerve cells. They are found throughout the body’s organs and help control many of the body’s functions. Hormones are chemical substances that are carried through the bloodstream to have...
-
Product Insights
Squamous Non-Small Cell Lung Cancer - Drugs In Development, 2024
Empower your strategies with our Squamous Non-Small Cell Lung Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) originating in the squamous cells lining the airways. It constitutes about 25-30% of all lung cancers. Linked to smoking, symptoms include persistent cough, chest pain, and breathing difficulties. Diagnosis involves imaging, biopsy, and staging to determine the cancer's extent. Treatment options depend on the stage but may...
-
Product Insights
Esophageal Squamous Cell Carcinoma (ESCC) - Drugs In Development, 2024
Empower your strategies with our Esophageal Squamous Cell Carcinoma (ESCC) – Drugs In Development, 2024 report and make more profitable business decisions. Esophageal squamous cell carcinoma (ESCC) is a type of cancer that arises from the squamous cells lining the esophagus, the muscular tube connecting the throat to the stomach. Commonly associated with tobacco and alcohol use, as well as dietary factors, ESCC is prevalent in certain geographic regions. Symptoms often manifest late and include difficulty swallowing, weight loss, and chest...
-
Product Insights
Peripheral T-Cell Lymphomas (PTCL) - Drugs In Development, 2024
Empower your strategies with our Peripheral T-Cell Lymphomas (PTCL) – Drugs In Development, 2024 report and make more profitable business decisions. Peripheral T-cell lymphomas (PTCL) constitute a diverse group of rare and aggressive non-Hodgkin lymphomas originating from mature T cells. These malignancies involve lymphoid tissues and may affect organs throughout the body. PTCLs are heterogeneous, comprising various subtypes with distinct clinical behaviors and outcomes. Symptoms may include enlarged lymph nodes, fever, weight loss, and night sweats. Diagnosis involves biopsies, imaging studies,...
-
Product Insights
Recurrent Glioblastoma Multiforme (GBM) - Drugs In Development, 2024
Empower your strategies with our Recurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024 report and make more profitable business decisions. Recurrent glioblastoma multiforme (GBM) refers to the return of aggressive brain tumors known as glioblastomas after initial treatment. GBM is the most malignant type of glioma, characterized by rapid growth and infiltrative behavior. Despite aggressive therapies like surgery, radiation, and chemotherapy, GBM often recurs due to its invasive nature and resistance to treatment. Management of recurrent GBM poses significant challenges....
-
Product Insights
Nasopharyngeal Cancer - Drugs In Development, 2024
Empower your strategies with our Nasopharyngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose, an area called the nasopharynx. The risk factors of nasopharyngeal cancer may include Epstein-Barr virus. Symptoms of nasopharyngeal cancer may include blurry or double vision, difficulty speaking including hoarseness, recurrent ear infections, face pain or numbness, headache, hearing loss, and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.